Clinical Trial

The COlchicine HypERtENsion Trial

Study acronym: COHERENT
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 22, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study to investigate the effects of colchicine on measures of vascular and cardiac function in patients with hypertension.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-06-03; most recent amendment 2025-12-15.
Status change: Recruiting → Active, Not Recruiting 2025-12-15
Status change: Not Yet Recruiting → Recruiting 2021-07-21
Trial Details
NCT Number NCT04916522
Lead Sponsor Herlev and Gentofte Hospital
Collaborators: University of Copenhagen
Conditions Hypertension
Enrollment 150 participants
Start Date 2021-08-10
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-22